Ranibizumab Ocular Implant Shows Long-Term Benefits in Retinal Disease

By News Health
1 day Ago

(MedPage Today) — The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and structural updates to the device…

Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/115925

Author :

Publish date : 2025-06-05 18:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mum of boy with PPFIBP1 gene says finding others gave her 'strength'

Novel Anticoagulant Flops for Staving Off Graft Thrombosis in Dialysis Patients

AI-Directed Breast MRI Could Lead to Faster Scan Times Without Affecting Accuracy

Home Testing Doubles Cervical Cancer Screening in Safety-Net Population

Infectious Disease Docs Slam New COVID Vaccine Recommendations

Some Psych Meds Tied to Higher Future Risk of ALS